
St. Petersburg's Bayfront hospital earns first ever A grade for safety
Nurses unions reported understaffing and equipment shortages that reportedly had led to high infection rates and unnecessary deaths. The 480-bed hospital had a D ranking for safety.
Five years on, hospital leaders are celebrating Bayfront's first ever A grade in new rankings released by Leapfrog, a nonprofit that rates hospitals nationwide on number of infections and medical errors. They gathered at the hospital at midnight Wednesday to celebrate with night shift workers.
'The team has been working so hard for a number of years,' said Jim Tucker, chief quality officer. 'People are thrilled to be celebrating today. It means everything.'
Most of the region's other larger hospitals, including St. Joseph's Hospital in Tampa, Morton Plant Hospital in Clearwater and St. Anthony's Hospital in St. Petersburg, also received an A grade.
But Tampa General Hospital received its fourth straight C rating despite assurances from hospital leaders that its grade would improve.
Hospital officials, however, point to the hospital's improved performance in a new ranking that placed it in the top 30% of academic medical centers in the nation. It was ranked in the 81st percentile of its peers in 2017.
The ranking, conducted by Vizient, is more significant since it compares Tampa General to hospitals of similar size and complexity, including NYU Langone, Mass General Brigham and Vanderbilt University, officials said.
'With technology, innovation and exceptional talent, Tampa General is continuously working to elevate quality, enhance safety and improve patient outcomes,' John Couris, hospital president and CEO, said in a statement.
Ten of 11 BayCare Health System hospitals that were rated received an A.
But the grade for HCA Florida Brandon Regional hospital dropped to a B with MRSA infections and the number of collapsed lungs flagged as areas of concern.
Eighteen of AdventhHealth's 26 Florida hospitals received an A grade. AdventHealth Tampa, the nonprofit's largest hospital in the Tampa Bay region, slipped from a B to a C after scoring below average for the number of blood and urinary tract infections.
The first ever A for Bayfront comes after significant investment in the hospital by Orlando Health. The hospital has a new ambulance bay expanding the number of ambulances that can be accommodated to 13. There is also new medical pavilions being constructed on campus.
Equipment in operating rooms, the labor and delivery department and the baby unit has also been upgraded. Surgical equipment used for neuro and orthopedic surgery has been replaced, new imaging equipment was purchased and sterile processing equipment improved.
The company also had to change the culture, said Tucker, who joined shortly before Orlando Health took over. Up until then, there were clearly challenges to address, including the number of infections in patients who had vascular catheters, also known as central lines, he said.
Now. there is an increased focus on minimizing the time that a patient is catheterized to reduce the likelihood of infections. The hospital has also been more successful at retaining nurses and surveys staff for ideas on how to keep improving safety.
'It's a never ending journey,' Tucker said. 'It's an infusion into the organization that has really helped us and will continue.'
Leapfrog has been rating and assessing hospitals for more than a decade in an effort to reduce deaths and injuries from hospital errors by publicly recognizing safety and exposing harm.
Twice a year it grades more than 3,000 acute-care hospitals across the U.S. twice a year on how well they keep patients safe from preventable harm and medical errors, using more than 30 performance measures that hospitals report to the Centers for Medicare and Medicaid Services.
But the nonprofit has been accused by a Palm Beach hospital operator of running a 'brazen pay-to-play scheme' publishing rankings that are 'false, wildly inaccurate, and defamatory.' Leapfrog charges hospitals between $6,700 and $29,900 per year to advertise their safety grade.
In a lawsuit filed this week in federal court, Palm Beach Health Network claimed that the grades awarded for 20% of hospitals that refuse to participate with Leapfrog are inaccurate and that the rating system punishes hospitals who decline to provide Leapfrog's safety survey.
The legal challenge names five of its hospitals — Delray Medical Center, Good Samaritan Medical Center, Palm Beach Gardens Medical Center, West Boca Medical Center and St. Mary's Medical Center — as victims of the rating system:
Leapfrog officials defended their rating system and said they provide important information that the public deserves to know.
'When we look at these hospitals' results from Center for Medicare and Medicaid Services, we see preventable suffering and death far exceeding the national average,' said Leapfrog President and CEO Leah Binder in a statement. 'Instead of using their resources to file frivolous lawsuits, they should be improving how their patients are treated.'

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


UPI
4 days ago
- UPI
Trial shows promise for new bloodborne staph infection treatment
The National Institute of Allergy and Infectious Diseases said a new treatment for bloodborne staph infections showed promise in a clinical trial. File Photo by Tamas Soki/EPA A new way to battle bloodborne staph infections could help save lives while combating the rise of antibiotic-resistant bacteria, according to new clinical trial results. Two intravenous doses of the antibiotic dalbavancin delivered seven days apart worked just as well as daily IV doses of conventional antibiotics in quelling Staphylococcus aureus bloodstream infections, researchers reported Wednesday in the Journal of the American Medical Association. "Given the small number of antimicrobial drugs available to treat Staphylococcus aureus bloodstream infections and the bacteria's growing drug resistance, establishing dalbavancin as a beneficial therapy for these severe infections gives us a vital new alternative to treat them," Dr. John Beigel said in a news release. He's acting director of microbiology and infectious diseases at the National Institute of Allergy and Infectious Diseases. NIAID sponsored and funded the trial, which involved 200 hospitalized adults with complicated staph blood infections treated at 23 medical centers in the U.S. and Canada. The patients were randomly assigned to receive either two doses of dalbavancin or daily IV antibiotics, with overall treatment lasting four to eight weeks. In all, 100 received dalbavancin and the same number had standard antibiotics. Dalbavancin is a relatively recent antibiotic discovery, approved by the U.S. Food and Drug Administration in May 2014, according to The standard antibiotics used depended on the type of staph a person had. Cefazolin or penicillin were used for regular staph, while vancomycin or daptomycin were implemented against antibiotic-resistant staph, also known as MRSA. Results showed that dalbavancin worked about as well as standard therapy, providing doctors a new option for treating a severe staph infection. "Our findings give patients and health care providers the data to support an extra choice when deciding on treatment for complicated S. aureus bacteremia," lead researcher Dr. Nicholas Turner, an assistant professor at Duke University School of Medicine in Durham, N.C., said in a news release. What's more, the dalbavancin was easier to deliver. People receiving daily antibiotics needed an implanted catheter that remained in place for the full duration of their treatment -- something that can lead to complications like blood clots and additional infections. By comparison, people receiving dalbavancin only needed a short catheter inserted twice for about an hour each time, researchers said. As a result, side effects like blood clots occurred more often in the standard treatment group compared to the dalbavancin group, researchers found. Serious side effects were about as common with dalbavancin as with standard antibiotics -- 40 cases versus 34 cases, results show. However, severe events leading to treatment discontinuation occurred in 12% of the standard treatment patients compared to 3% of those treated with dalbavancin. Researchers next plan to compare the cost-effectiveness of the two approaches. More information The Cleveland Clinic has more about staph infections. Copyright © 2025 HealthDay. All rights reserved.

5 days ago
High level of multidrug-resistant bacterial infections in Gaza, analysis finds
Cases of multidrug-resistant bacterial infections are high in Gaza amid the ongoing Israel-Hamas war, a new analysis finds. The widespread prevalence of multidrug-resistant bacteria is expected to complicate the treatment of patients in the war-torn region, where medical supplies, including medicines, are in short supply due to insufficient aid flowing in. The team that analyzed the data -- from Gaza and the U.S. -- looked at around 1,300 specimens collected by Al-Ahli Hospital in Gaza City in the northern part of the strip, between Nov. 1, 2023, and Aug. 31, 2024. Multidrug resistance was defined as a bacterium that couldn't be killed by at least one drug in three or more classes. About two-thirds, or 66.9%, of the samples that were assessed were found to be multidrug-resistant, according to the peer-reviewed research comment published Tuesday in the medical journal The Lancet. The bacteria were resistant to antibiotics, including amoxicillin–clavulanate, cefuroxime, and cefotaxime, according to the analysis. The analysis also found that resistance to two antibiotics, ceftriaxone and ceftazidime, was high among bacteria found growing in infected wounds. Researchers also detected the presence of MRSA -- or Methicillin-resistant Staphylococcus aureus -- a type of bacteria that is resistant to several antibiotics, in some samples. The team also compared two periods of the war, the first from Nov 1, 2023, to March 31, 2024, and the second from April 1, 2024, to Aug 31, 2024. They found that the prevalence of multidrug resistance was relatively unchanged, from 66.7% to 68.2%, respectively during the two periods that were analyzed. Bilal Irfan, co-author of the analysis and a bioethicist who conducts research at Harvard's Brigham and Women's Hospital and the University of Michigan, told ABC News that the collapse of Gaza's health care system has exacerbated the spread of multidrug-resistant bacterial infections. "With widespread deliberate targeting of hospitals, laboratories, water desalination plants, that's even harder to assess the infection burden or the antibiotic resistance burden because the laboratories that would be assessing this sort of stuff are either destroyed or out of the service whether they're in universities or hospitals," Irfan said. "The health care staff that would be regularly doing this have either been killed, abducted or otherwise, displaced so even getting a picture of all this, it's very difficult." Israel has claimed that Hamas uses hospitals, and networks of tunnels beneath them, as bases to conduct and promote terrorist activity, and U.S. officials have backed this claim. Hamas, however, has repeatedly denied it. Irfan said the attacks on hospitals and the displacement of families sheltering around hospitals can contribute to the transmission of infectious diseases, including multidrug-resistant bacterial infections. "So, all of these risks obviously require, first and foremost, an end to the chronic hostilities, but also the reconstruction has to involve Palestinian stakeholders who have been in Gaza, who understand kind of the situation of the health system and how to actually rebuild it and how to repair it," Irfan said. "A lot of these things are not going to be solved even when you have ceasefire. It's gonna take years, if not decades, to even reverse at least some of these numbers and some of these crises." A December 2024 report from the U.N. Human Rights Office found that Israel has established "a pattern of deadly attacks" on and near hospitals in Gaza. U.N. experts have also called for the protection of health care workers in Gaza, many of whom have been killed or detained in the ongoing war. The international medical community has a "duty to act and respond" by calling for a ceasefire and helping stabilize laboratories in Gaza, the authors wrote. The team also called for a coordinated response from humanitarian agencies and donors to the drug supply needs of hospitals. The analysis suggested that the depletion of stockpiles of broad-spectrum antibiotics has likely contributed to the rise of multidrug resistance.
Yahoo
01-08-2025
- Yahoo
New Nimbus & Stratus COVID Variants Are Spreading—Here's Why Midlife Women Should Be Concerned
If it seems like more people have been getting COVID-19 lately, it's not your imagination. According to the Centers for Disease Control and Prevention (CDC), infections are increasing, or likely increasing, in more than half of the states—and they're not declining in any. At the moment, two new strains of the virus—Nimbus and Stratus—are making the rounds. Both appear to be derivatives of the omicron strain, says Dr. Daniel Egan, an infectious disease physician at Orlando Health. More from Flow Space Is There Really About to Be a Breast Cancer Vaccine? A key symptom of the Nimbus strain is a severe sore throat that many are calling 'razor blade throat,' says Dr. Bernadette Boden-Albala, an epidemiologist and the director and founding dean of the UC Irvine Joe C. Wen School of Population & Public Health. 'This very sore throat is also associated with a raspy or strained voice,' she explains. 'Other common symptoms mirror previous COVID strains like runny nose, headache, difficulty breathing and fatigue.' After contracting COVID in late June, I can confirm that 'razor blade throat' is an accurate descriptor for what you experience with this strain. It felt like there were sharp knives lining the inside of my throat, which was the symptom that prompted me to take a COVID test in the first place—especially with the rise in cases this summer. But this isn't like the summer waves of the past few years, when COVID vaccines were readily available to everyone. In May, Food and Drug Administration (FDA) officials announced that annual COVID-19 boosters will be limited to people aged 65 and older, and those with certain medical conditions that put them at high risk for severe infection. This new policy leaves millions of midlife women without up-to-date protection from the vaccine. Not only that, but the threat of long COVID very much still exists—especially for women. In fact, a recently published peer-reviewed study found that women had a three-fold higher risk of being diagnosed with long COVID, and the risk rises more with age. Here's what to know about this year's summer COVID wave and why midlife women should be concerned. What Is Causing COVID Cases to Spike? The Nimbus and Stratus variants have mutations that help them dodge prior immunity, so they spread easily, says Dr. Julio Baute, a physician and the clinical content and evidence-based medicine consultant at Invigor Medical. While these two variants are responsible for the majority of COVID cases in the U.S. this summer, there is no evidence that they're more severe than previous Omicron strains, he explains. Egan says that he's seen a few more cases than usual in his hospital, but overall, he's not seeing infected patients transferred to the ICU. According to Boden-Albala, we're seeing an uptick in COVID-19 cases this summer because of a combination of seasonal factors. 'Just like other respiratory viruses, COVID-19 tends to spread more easily when people are spending more time indoors—often to escape the heat—in close contact with others and in air-conditioned spaces with limited ventilation,' she explains. 'Traveling by air, large gatherings and relaxed precautions also contribute to increased transmission.' On top of that, people tend to ignore their symptoms during the summer, and instead of staying home to recover, they continue on with their activities, potentially getting sicker as well as spreading the virus, Boden-Albala notes. 'While many people have some immunity from past infection or vaccination, the virus continues to evolve, and even mild cases can have serious ripple effects, particularly for those who are immunocompromised or at higher risk,' she adds. What About COVID Vaccines? Here's where things get tricky. Although the FDA no longer recommends COVID boosters for healthy people under the age of 65, Boden-Albala says that 'most pharmacies are still providing vaccine boosters,' so you should check around and get a booster if you haven't had one in a while. According to the World Health Organization, the currently approved COVID-19 vaccines are expected to remain effective against the new variants as far as preventing severe disease. Additionally, vaccination is associated with a lower risk of long COVID, Baute says. That's even more reason to get a booster if you can. Is Long COVID Still a Threat? In short, yes—especially for women, who are disproportionately affected by the constellation of symptoms and conditions. In other words, if you contract COVID, there's still a chance of ending up with long COVID—though staying up-to-date with vaccinations does reduce that risk. A recent study exploring the association between female gender and long COVID syndrome also demonstrated that 'advanced age was associated with ongoing fatigue and musculoskeletal pain, or impairment in pulmonary functions, reflecting a decline in organ function and a slower ability to recover,' Boden-Albala points out. Although it's still unclear why women are more likely to end up with long COVID, this is in line with women being disproportionately impacted by other chronic conditions like ME/CFS, fibromyalgia and multiple sclerosis. 'The scientific community is unraveling the role hormones play in perpetuating the severity of COVID, even after recovery,' Boden-Albala says. According to Baute, sex-based immune responses, hormone influences, differences in autoimmune susceptibility and social factors may contribute to the fact that women are more likely to end up with long COVID than men. 'Evidence is suggestive, not conclusive, but more studies are needed,' he says. As one of the millions of Americans living with long COVID, I can assure you that you don't want to end up with any of the more than 200 symptoms associated with the condition, like constant exhaustion, cognitive issues, exercise intolerance, persistent headaches, sleep disturbances, shortness of breath, a fast or irregular heartbeat, depression and anxiety. While treatments are available to help manage the symptoms, there's currently no cure for long COVID. The best way to avoid long COVID is by not contracting COVID in the first place. How Can Midlife Women Protect Themselves Against COVID? The best way to protect yourself against COVID is to stay up-to-date with your vaccines, if possible, Boden-Albala says. 'The updated COVID-19 vaccines are designed to target circulating variants more effectively,' she explains. 'Staying current offers the best protection against severe illness, especially for people with higher risk factors such as midlife hormonal changes that can impact immunity or pre-existing health conditions.' Even though the FDA is limiting COVID-19 vaccines to those aged 65 and older, there is a way around the new restriction: people with certain risk factors will still be allowed to get regular boosters. The FDA's list of eligible conditions, which was published in the New England Journal of Medicine along with the rest of the guidelines, are exceptionally vague, to the point where many people can claim eligibility based on obesity (BMI of 30 or higher) or 'physical inactivity.' Whether or not you're able to get a COVID booster, Baute recommends layered risk-reduction strategies, like ventilating rooms, masking in crowded indoor spaces during surges, testing early if symptomatic and seeking treatment promptly if you're at higher risk of contracting the infection. Additionally, do what you can to keep your immune system strong. 'Midlife women often juggle caregiving, careers, and hormonal shifts that can strain the immune system,' Boden-Albala says. 'Maintaining a strong baseline of health through proper sleep, exercise, nutrient-rich food and stress reduction can support immune resilience.' Solve the daily Crossword